Titan Health Partners Llc

CLIA Laboratory Citation Details

3
Total Citations
9
Total Deficiencyies
8
Unique D-Tags
CMS Certification Number 31D1048082
Address 9 Centre Drive, Monroe Township, NJ, 08831
City Monroe Township
State NJ
Zip Code08831
Phone732 390-7750
Lab DirectorROBERT FEIN

Citation History (3 surveys)

Survey - September 24, 2024

Survey Type: Standard

Survey Event ID: WUTK11

Deficiency Tags: D5421

Summary:

Summary Statement of Deficiencies D5421 ESTABLISHMENT AND VERIFICATION OF PERFORMANCE CFR(s): 493.1253(b)(1) Each laboratory that introduces an unmodified, FDA-cleared or approved test system must do the following before reporting patient test results: (1)(i) Demonstrate that it can obtain performance specifications comparable to those established by the manufacturer for the following performance characteristics: (1)(i)(A) Accuracy. (1)(i) (B) Precision. (1)(i)(C) Reportable range of test results for the test system. (1)(ii) Verify that the manufacturer's reference intervals (normal values) are appropriate for the laboratory's patient population. This STANDARD is not met as evidenced by: Based on surveyor review of the Horiba Micros 60 Performance Specification (PS) records and interview with the Laboratory Manager (LM), the laboratory failed to ensure that all PS records were adequate for all analytes run on the Horiba Micros 60 Analyzer from 5/1/22 to 9/24/24. The findings include: 1. There was no documented evidence that the Laboratory Information System (LIS) was verified before routine patient testing. 2. The LM confirmed on 9/24/24 at 10:50 am that the laboratory failed to ensure that all PS records were adequate. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 29, 2021

Survey Type: Standard

Survey Event ID: OBEP11

Deficiency Tags: D5401 D5781

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on surveyor review of the Procedure Manual (PM), Operators Manual (OM) and interview with the Technical Consultant (TC), the laboratory failed to follow the PM for calibrating the the Cell-Dyn Emerald analyzer from 10/29/19 to the date of the survey. The findings include: 1. The PM stated under "Pre-Calibration Procedure Checklist" to "Verify Instrument precision by running a fresh, normal whole blood specimen ten times into the PRECISION file." 2. The laboratory did not perform the aforementioned procedure when calibrating the Abbot Cell-Dyn Emerald. 3. The TC confirmed 7/29/21 at 10:30 am that the laboratory did not follow the PM. D5781

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 29, 2019

Survey Type: Standard

Survey Event ID: OPEQ11

Deficiency Tags: D5415 D5469 D5481 D6074 D5401 D5779

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: a. Based on surveyor review of the Procedure Manual (PM) and interview with the Technical Consultant (TC), the laboratory failed to follow the procedure for reviewing results with flags obtained on the Cell Dyne Emerald analyzer used for Hematology testing from January 2019 to the date of survey. The finding includes: 1. The PM stated to remix and rerun samples with a flagged result but a review of ten patient results with flags revealed the laboratory did not rerun ten out of ten patients. 2. The TC confirmed on 10/29/19 at 11:00 am that the laboratory did not follow the procedure for flag review. b) Based on surveyor review of the Abbott Cell Dyne Emerald Operators Manual, PM and interview with the TC, the laboratory failed to follow the instrument calibration procedure for Hematology tests performed on the Cell-Dyne Emerald analyzer from 9/17/18 to the date of survey. The finding includes: 1. The PM stated calibration must be run every six months but the laboratory calibrated on November 2018 and July 2019. 2. The TC confirmed on 10/29/19 at 11: 10 am that the PM not followed. D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: Based on surveyor review of Manufactures Package Insert, observation of the Quality Control material, and interview with the Technical Consultant (TC), the laboratory failed to put a new expiration date on Hematology Control material used on the Cell Dyne Emerald on the date of the survey. The TC confirmed on 10/29/19 at 10:20 am the laboratory failed to put a new expiration date on the control material. D5469 CONTROL PROCEDURES CFR(s): 493.1256(d)(10)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- Establish or verify the criteria for acceptability of all control materials. (i) When control materials providing quantitative results are used, statistical parameters (for example, mean and standard deviation) for each batch and lot number of control materials must be defined and available. (ii) The laboratory may use the stated value of a commercially assayed control material provided the stated value is for the methodology and instrumentation employed by the laboratory and is verified by the laboratory. (iii) Statistical parameters for unassayed control materials must be established over time by the laboratory through concurrent testing of control materials having previously determined statistical parameters. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on surveyor review of Quality Control records and interview with the Technical Consultant (TC), the laboratory failed to verify commercially assayed QC material with each new lot and/or shipment of Hematology QC used on the Cell Dyne Emerald analyzer from 9/19/17 to the date of survey. The findings include: 1. There was no documented evidence to show QC was verified in the calendar year 2108. 2. The procedure stated to run QC five times on different days but Lot 9154 expired on 9/20 /19 and QC Lot 9238 was run five times and verified on 9/23/19. 3. There were no instrument printout to show QC Lot 8267 and 8351 were verified. 4. The TC confirmed on 10/29/19 at 11:15 am that all assayed QC material was not verified before putting in use. D5481 CONTROL PROCEDURES CFR(s): 493.1256(f)(g) (f) Results of control materials must meet the laboratory's and, as applicable, the manufacturer's test system criteria for acceptability before reporting patient test results. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on surveyor review of Quality Control (QC) records and interview with the Technical Consultant (TC), the laboratory failed to ensure control results were within manufacturers acceptable range each day of patient testing for Hematology Tests performed on the Cell Dyne Emerald analyzer from in May and June 2019. The -- 2 of 4 -- findings include: 1. A review of the QC record for Lot 9070 revealed two of three levels of QC were not within range for parameters below: a. Platelets - Normal and Low QC on 5/30/19 b. Mean Corpuscular Volume (MCV) - Normal and High 6/28/19 c. White Blood Counts (WBC) - Normal and High 6/6/19, 6/10/19, 6/14/19 and 6/17 /19 2. Approximately 30 patients were run on each date listed above. 3. The TC confirmed on 10/29/19 at 11:35 am that patient results were reported when QC results were out. D5779

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access